Universe Pharmaceuticals Stock Forecast - Triple Exponential Smoothing
| UPC Stock | USD 4.10 0.03 0.74% |
Universe Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Universe Pharmaceuticals stock prices and determine the direction of Universe Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Universe Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the RSI of Universe Pharmaceuticals' share price is approaching 47. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Universe Pharmaceuticals, making its price go up or down. Momentum 47
Impartial
Oversold | Overbought |
Quarterly Earnings Growth (0.82) | Quarterly Revenue Growth (0.29) |
Using Universe Pharmaceuticals hype-based prediction, you can estimate the value of Universe Pharmaceuticals from the perspective of Universe Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Triple Exponential Smoothing forecasted value of Universe Pharmaceuticals on the next trading day is expected to be 4.08 with a mean absolute deviation of 0.20 and the sum of the absolute errors of 11.62. Universe Pharmaceuticals after-hype prediction price | USD 4.1 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Universe Pharmaceuticals to cross-verify your projections. Universe Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Universe price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Universe using various technical indicators. When you analyze Universe charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Universe Pharmaceuticals Triple Exponential Smoothing Price Forecast For the 29th of January
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Universe Pharmaceuticals on the next trading day is expected to be 4.08 with a mean absolute deviation of 0.20, mean absolute percentage error of 0.10, and the sum of the absolute errors of 11.62.Please note that although there have been many attempts to predict Universe Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Universe Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Universe Pharmaceuticals Stock Forecast Pattern
| Backtest Universe Pharmaceuticals | Universe Pharmaceuticals Price Prediction | Buy or Sell Advice |
Universe Pharmaceuticals Forecasted Value
In the context of forecasting Universe Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Universe Pharmaceuticals' downside and upside margins for the forecasting period are 0.04 and 11.31, respectively. We have considered Universe Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Universe Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Universe Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.0488 |
| MAD | Mean absolute deviation | 0.1969 |
| MAPE | Mean absolute percentage error | 0.0466 |
| SAE | Sum of the absolute errors | 11.617 |
Predictive Modules for Universe Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Universe Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Universe Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Universe Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Universe Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Universe Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Universe Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Universe Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Universe Pharmaceuticals' historical news coverage. Universe Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.21 and 11.28, respectively. We have considered Universe Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Universe Pharmaceuticals is very risky at this time. Analysis and calculation of next after-hype price of Universe Pharmaceuticals is based on 3 months time horizon.
Universe Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Universe Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Universe Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Universe Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.02 | 7.23 | 0.00 | 0.00 | 5 Events / Month | 5 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
4.10 | 4.10 | 0.00 |
|
Universe Pharmaceuticals Hype Timeline
On the 28th of January Universe Pharmaceuticals is traded for 4.10. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Universe is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.02%. %. The volatility of related hype on Universe Pharmaceuticals is about 6820.75%, with the expected price after the next announcement by competition of 4.10. The company has Price to Book (P/B) ratio of 0.04. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Universe Pharmaceuticals recorded a loss per share of 255.68. The entity had not issued any dividends in recent years. The firm had 1:40 split on the 24th of March 2025. Considering the 90-day investment horizon the next projected press release will be in about 5 days. Check out Historical Fundamental Analysis of Universe Pharmaceuticals to cross-verify your projections.Universe Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Universe Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Universe Pharmaceuticals' future price movements. Getting to know how Universe Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Universe Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PRFX | Painreform | (0.06) | 8 per month | 0.00 | (0.08) | 9.38 | (9.48) | 53.02 | |
| NKGN | NKGen Biotech Common | 0.00 | 0 per month | 0.00 | 0.22 | 20.00 | (1.96) | 68.90 | |
| ELAB | Elevai Labs Common | 0.06 | 9 per month | 0.00 | (0.42) | 5.71 | (14.29) | 38.62 | |
| BJDX | Bluejay Diagnostics | (0.32) | 5 per month | 0.00 | (0.31) | 7.69 | (10.11) | 30.03 | |
| TIVC | Tivic Health Systems | (0.32) | 9 per month | 0.00 | (0.14) | 10.43 | (12.23) | 46.76 | |
| WINT | Windtree Therapeutics | 0.01 | 7 per month | 0.00 | (0.21) | 20.00 | (20.00) | 58.33 | |
| MLEC | Moolec Science SA | (0.21) | 9 per month | 10.55 | 0.03 | 15.63 | (16.33) | 152.55 | |
| BCTXZ | BriaCell Therapeutics Corp | 0.00 | 0 per month | 0.00 | (0.06) | 18.52 | (19.05) | 69.68 | |
| SHPH | Shuttle Pharmaceuticals | (0.19) | 7 per month | 0.00 | (0.04) | 15.69 | (14.37) | 44.53 | |
| NCEL | NewcelX | (0.03) | 21 per month | 0.00 | (0.17) | 10.12 | (14.40) | 39.40 |
Other Forecasting Options for Universe Pharmaceuticals
For every potential investor in Universe, whether a beginner or expert, Universe Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Universe Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Universe. Basic forecasting techniques help filter out the noise by identifying Universe Pharmaceuticals' price trends.Universe Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Universe Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Universe Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Universe Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Universe Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Universe Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Universe Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Universe Pharmaceuticals stock market strength indicators, traders can identify Universe Pharmaceuticals entry and exit signals to maximize returns.
Universe Pharmaceuticals Risk Indicators
The analysis of Universe Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Universe Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting universe stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.63 | |||
| Standard Deviation | 7.12 | |||
| Variance | 50.69 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Universe Pharmaceuticals
The number of cover stories for Universe Pharmaceuticals depends on current market conditions and Universe Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Universe Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Universe Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Universe Pharmaceuticals Short Properties
Universe Pharmaceuticals' future price predictability will typically decrease when Universe Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Universe Pharmaceuticals often depends not only on the future outlook of the potential Universe Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Universe Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6077.00 | |
| Cash And Short Term Investments | 29.5 M |
Check out Historical Fundamental Analysis of Universe Pharmaceuticals to cross-verify your projections. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Universe Pharmaceuticals. If investors know Universe will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Universe Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.82) | Earnings Share (255.68) | Revenue Per Share | Quarterly Revenue Growth (0.29) | Return On Assets |
The market value of Universe Pharmaceuticals is measured differently than its book value, which is the value of Universe that is recorded on the company's balance sheet. Investors also form their own opinion of Universe Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Universe Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Universe Pharmaceuticals' market value can be influenced by many factors that don't directly affect Universe Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Universe Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Universe Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universe Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.